Datamonitor's Rx-to-OTC Strategies

Maximizing the Commercial Potential of an Rx-to-OTC Switch

Product Description:

With the growing cost of developing novel drugs, combined with the fact that fewer such drugs are gaining regulatory approval year-on-year, the use of lifecycle management is playing a greater role in the increasingly cost-conscious pharma industry. Rx-to-OTC switching is one such strategy employed to either enhance existing franchise revenues or protect branded revenues from generic competition. However, execution of the switch is crucial to the future success of the OTC product.

Datamonitor's special report Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch provides

  • Overview of the Rx-to-OTC strategy, analyzing why, when, where, what and how to implement such a switch strategy
  • Identification of drivers and resistors of Rx-to-OTC switching across the seven major pharmaceutical markets
  • Case study analysis of the most recent Rx-to-OTC switches
  • Rx-to-OTC trend data and analysis, supported by 20 key strategic recommendations to maximize the commercial success of an Rx-to-OTC switch

Click here to view the 10-page executive summary of this report.

Reasons to Purchase:

  • Identify the recent trends in the Rx-to-OTC market, including which are the most popular OTC indications, and who is implementing Rx-to-OTC switches
  • Gain insight into the drivers and resistors of implementing Rx-to-OTC switches across the seven major markets
  • Understand how to execute a switch strategy to enhance existing franchise revenues or protect branded revenues from generic competition

Enhance existing franchise revenues and protect branded revenues from generic competition by ordering Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch today.

The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail account manager Maureen Croce at mcroce@hcpro.com.

Click here to view the 10-page executive summary of this report.

Save money when you purchase multiple copies! Ask your customer service representative about money-saving discounts and bulk orders. Call toll free 800-650-6787 or e-mail customerservice@hcpro.com.
Publisher :  Datamonitor
 
Product Types : Departments :
This special report details the recent trend of Rx-to-OTC switching, which is being used more frequently to either enhance existing franchise revenues or protect branded revenues from generic competition. Purchasers will gain insight into the drivers and resistors of implementing Rx-to-OTC switches across the seven major markets, as well as understand how to execute a switch strategy, which may be crucial to the future success of the OTC product.
Email Print
ORDER CODE: DRXOTC
SOURCE CODE: ESEARCHGOO

Related Products